Gastrointestinal Over-The-Counter (OTC) Drugs Market Forecast Through 2030 With Insights On Market Patterns And Developments
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market During The Forecast Period?
The gastrointestinal over-the-counter (otc) drugs market size has shown robust expansion in recent years. It is projected to rise from $49.59 billion in 2025 to $53.74 billion by 2026, achieving a compound annual growth rate (CAGR) of 8.4%. The historic period’s growth can be linked to the widespread occurrence of digestive disorders, improved otc drug accessibility, the expansion of pharmacy retail, evolving urban lifestyles, and shifts in dietary habits.
The gastrointestinal over-the-counter (otc) drugs market is projected to experience substantial expansion in the coming years. This market is forecast to reach $73.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth during the forecast period include the increasing adoption of preventive digestive care, the expansion of e-commerce, a rising demand for clean-label OTC products, an aging global population, and heightened awareness of digestive health. Key trends anticipated during the same period encompass an increase in self-medication for digestive issues, a heightened need for rapid-acting OTC relief, a surge in the utilization of combination gastrointestinal products, the growth of online pharmacy sales, and an evolving preference for products based on herbs and enzymes.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24547&type=smp
Which Strong Drivers Are Impacting The Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth?
The increasing occurrence of digestive ailments is projected to propel the expansion of the gastrointestinal OTC drugs market moving forward. Digestive disorders encompass various conditions that affect the gastrointestinal tract, including the stomach, intestines, and associated organs. The uptick in digestive problems is primarily attributed to higher consumption of processed, low-fiber foods, which disrupt gut health and impair digestion. Gastrointestinal OTC drugs mitigate digestive disorder symptoms by reducing stomach acid, regulating bowel movements, and enhancing overall gut health. These medications offer rapid and convenient relief from common issues such as acidity, constipation, and indigestion. For instance, in December 2023, according to the IBD Registry Ltd., a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) reached over 5,300, marking an increase of more than 3,000 members compared to 2022. Thus, the rising prevalence of digestive disorders is a key driver for the growth of the gastrointestinal OTC drugs market.
Which Segment Categories Are Included In The Gastrointestinal Over-The-Counter (OTC) Drugs Market Segment Analysis?
The gastrointestinal over-the-counter (otc) drugs market covered in this report is segmented –
1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products
2) By Formulation: Tablets, Capsules, Liquids, Other Formulations
3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids
2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives
3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions
4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements
5) By Other Products: Digestive Enzymes, Simethicone, Herbal Remedies, Activated Charcoal
What Trends Are Influencing The Evolution Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
Leading companies operating in the gastrointestinal OTC drugs market are concentrating on developing advanced products, such as over-the-counter proton pump inhibitors, to deliver effective and long-lasting relief from acid-related disorders. Over-the-counter (OTC) proton pump inhibitors (PPIs) are a class of medications available without a prescription that reduce the production of stomach acid. They are commonly used to treat conditions like frequent heartburn, acid reflux (GERD), and gastric ulcers. For instance, in March 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, secured approval in Japan to transition its Pariet S (rabeprazole sodium 10 mg) from prescription (RX) to over-the-counter (OTC) status, establishing it as the first OTC PPI in Japan to contain the same active ingredient and dosage as its prescription product. Pariet S is indicated for stomach pain, heartburn, and bloating, offering 24-hour relief with a once-daily, easy-to-swallow tablet, and aims to address the growing need for effective gastric acid-related treatments due to lifestyle and demographic changes.
Who Are The Active Companies Shaping The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
Major companies operating in the gastrointestinal over-the-counter (otc) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd.
Get The Full Gastrointestinal Over-The-Counter (OTC) Drugs Market Report:
Which Region Has The Greatest Market Share In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (otc) drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gastrointestinal Over-The-Counter (OTC) Drugs Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Gastrointestinal Over-The-Counter (OTC) Drugs Market 2026, By The Business Research Company
Colorectal Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report
Otc Drug And Dietary Supplement Market Report 2026
Gastroparesis Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
